NPIC
Neumeier Poma Investment Counsel’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-550,676
| Closed | -$15.1M | – | 44 |
|
|
2019
Q3 | $15.1M | Sell |
550,676
-406,725
| -42% | -$11.2M | 1.26% | 34 |
|
|
2019
Q2 | $31.7M | Buy |
957,401
+10,170
| +1% | +$337K | 2.62% | 16 |
|
|
2019
Q1 | $33.2M | Buy |
947,231
+452,900
| +92% | +$15.9M | 2.79% | 16 |
|
|
2018
Q4 | $16.4M | Buy |
494,331
+23,071
| +5% | +$766K | 1.56% | 31 |
|
|
2018
Q3 | $23.7M | Buy |
471,260
+45,010
| +11% | +$2.27M | 1.96% | 23 |
|
|
2018
Q2 | $25.5M | Sell |
426,250
-97,100
| -19% | -$5.81M | 2.37% | 19 |
|
|
2018
Q1 | $24M | Buy |
523,350
+855
| +0.2% | +$39.2K | 2.47% | 15 |
|
|
2017
Q4 | $20.8M | Sell |
522,495
-198,925
| -28% | -$7.93M | 2.09% | 25 |
|
|
2017
Q3 | $28.9M | Sell |
721,420
-169,320
| -19% | -$6.77M | 3.02% | 13 |
|
|
2017
Q2 | $38.4M | Buy |
890,740
+14,430
| +2% | +$622K | 4.47% | 3 |
|
|
2017
Q1 | $27.4M | Buy |
876,310
+97,610
| +13% | +$3.06M | 3.28% | 10 |
|
|
2016
Q4 | $19.7M | Sell |
778,700
-244,240
| -24% | -$6.17M | 2.71% | 20 |
|
|
2016
Q3 | $25.3M | Sell |
1,022,940
-190,615
| -16% | -$4.71M | 3.79% | 4 |
|
|
2016
Q2 | $24.7M | Buy |
1,213,555
+9,625
| +0.8% | +$196K | 3.91% | 5 |
|
|
2016
Q1 | $18.4M | Buy |
1,203,930
+302,600
| +34% | +$4.61M | 2.91% | 14 |
|
|
2015
Q4 | $12.1M | Buy |
+901,330
| New | +$12.1M | 2.09% | 27 |
|